Clinical Trials Browser

Phase 2 × Terminated × tagraxofusp × Clear all

NCT04342962 2025-01-30

Tagraxofusp in Patients With CD123+ or With BPDCN-IPh-like Acute Myeloid Leukemia

Phase 2 Terminated

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT04317781 2024-07-31

Tagraxofusp in Treating Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm After Stem Cell Transplant

Phase 2 Terminated

3 enrolled 8 charts

Blastic Plasmacytoid Dendritic Cell Neoplasm